Dr. David Hoffman, MD
Claim this profileTower Hematology Oncology Medical Group
Affiliated Hospitals
Tower Hematology Oncology Medical Group (THO)
CS Cancer Beverly Hills
Clinical Trials David Hoffman, MD is currently running
Apalutamide + Carotuximab
for Prostate Cancer
This is an open-label, multi-site study of apalutamide with carotuximab in patients who have progressed on androgen receptor signaling inhibitor (ARSI) therapy. This study will begin with a safety assessment in the first 10 subjects (part 1: Safety Lead-in). If the combination is deemed safe, the trial will proceed to the Phase II stage. The purpose of this study is to compare progression free survival (PFS) between patients receiving apalutamide and apalutamide + carotuximab using Response Evaluation Criteria in Solid Tumors (RECIST 1.1) and Prostate Cancer Working Group 3. The secondary objectives are to describe adverse events related to the intervention, overall response rate (ORR), proportion of patients resistant to apalutamide that benefit from the addition of carotuximab, and to determine the ORR, radiographic PFS, and biochemical PFS in the overall population.
Recruiting
1 award
Phase 2
Cisplatin
for Oropharyngeal Cancer
This is a single institution phase II study that will enroll patients with T0-3N0-2 p16-positive oropharyngeal squamous cell carcinoma (OSCC) undergoing resection of all gross visible disease at the primary site and in the lymph nodes.
Recruiting
1 award
Phase 2
7 criteria
More about David Hoffman, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments David Hoffman, MD has experience with
- Keytruda
- Telatinib
- Gemcitabine
- L-glutamine
- Nab-paclitaxel
- Apalutamide
Breakdown of trials David Hoffman, MD has run
Hepatocellular Carcinoma
Stomach Cancer
Pancreatic Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Hoffman, MD specialize in?
David Hoffman, MD focuses on Liver Cancer and Hepatocellular Carcinoma. In particular, much of their work with Liver Cancer has involved treating patients, or patients who are undergoing treatment.
Is David Hoffman, MD currently recruiting for clinical trials?
Yes, David Hoffman, MD is currently recruiting for 2 clinical trials in Beverly Hills California. If you're interested in participating, you should apply.
Are there any treatments that David Hoffman, MD has studied deeply?
Yes, David Hoffman, MD has studied treatments such as Keytruda, Telatinib, Gemcitabine.
What is the best way to schedule an appointment with David Hoffman, MD?
Apply for one of the trials that David Hoffman, MD is conducting.
What is the office address of David Hoffman, MD?
The office of David Hoffman, MD is located at: Tower Hematology Oncology Medical Group, Beverly Hills, California 90211 United States. This is the address for their practice at the Tower Hematology Oncology Medical Group.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.